OK, here is what is bouncing around in my head. C
Post# of 148292
On Thursday the company PR'd their intent to seek approval in US, UK and other countries for COVID (and HIV).
On Friday, Nader stated that we had achieved statistical significance in an endpoint (parameter).
I'm trying to decide if the data analysis was complete on Thursday/Friday and they havent released it yet. Or if the data was not yet complete on Thursday/Friday.
If the data was complete on Thursday, then they have 4 business days to disclose it.
If the data was not yet complete, then its possible that more endpoints may be met.
(its also possible that NP misspoke and more endpoints were hit)
What keeps bringing my mind back to this is the PR that we will be submitting to the FDA this week. It would seem to me that quite a bit of work goes into packaging a submission for the FDA. Either they had the data some time ago, and are working on the submission now, or they didnt have the data complete and are going to have to rush the submission/miss the self imposed deadline.